Publisher Correction: Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype
Degao Chen(Army Medical University), Bo Huang(Southwest University of Science and Technology), Feiran Cheng(Standard Bio (Norway)), Yabo Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinyan Liu(Beth Israel Deaconess Medical Center), Roland Fiskesund(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiadi Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Yi Zhang(Tianjin Medical University General Hospital), Yuying Liu(Tianjin University of Science and Technology), Ke Tang(Sun Yat-sen University), Xiaoyu Liang(Sun Yat-sen University), Jingwei Ma(Huazhong University of Science and Technology), Jing Xie(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenqian Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Xun Jin(Tianjin Medical University Cancer Institute and Hospital), Tianzhen Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Siqi Mo(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 27
Related Papers
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Roles of IFN-γ in tumor progression and regression: a review
|Biomarker Research|2020|1.2k